Regional Sales Manager

• Apr 2021 - Present

Senior Professional Sales Representative

• Jun 2019 - Aug 2020

Sold nebulized maintenance therapy for the treatment of COPD in the Atlanta South/Columbus territory. Target points included Pulmonologists, Allergists, Respiratory therapists and Internal Medicine. Successful sales results amid COVID-19 challenges. Worked closely with hospital counterparts, DME companies, retail pharmacies and office staff for successful Rx pull through for Medicare B patients. • Launched 1st and only once daily nebulized LAMA (Yupelri) in Atlanta South territory • Outpaced district, region, and nation in 2020 YTD volume growth (641% TRx growth thru June) • Increased number of Yupelri writers from 7 to 35 in less than 9 months • Embraced “virtual” sales approach and led the district in “Zoom” LNLs and other digital resources Show less

CVM field sales/Janssen Pharmaceuticals

• Mar 2018 - Jun 2019

Sold cardiovascular and diabetes products in Fayetteville territory. Target points included Cardiologists, Endocrinologists, Internal Medicine and Nephrologists. • Increased Invokana sales despite declining SGLT2 market. • Launched new indication for Invokana to further reduce CV risks in patients with established T2D. • Launched new Xarelto indication creating awareness surrounding chronic stable CAD/PAD. • Improved overall ranking from 820/966 to 399/966 in 9-month time frame. • Finished in top 10% 2nd QTD 2019 Show less

Excecutive Sales Professional

• Mar 2001 - 2017

Three time Presidents Club winner. 6 years of Injectable, Biologic and Device experience marketing Lantus and Toujeo in highly competitive diabetes market. • National Sales Champion in 2012 (Presidents Club) • Launched new basal insulin Toujeo in April 2015 resulting in top 30% by year end • Increased ranking from 217 to124 in 6 months in a low performing territory in 2016 • Winner of metrics driven “Step Up” contest and recognized for highest activity in the territory for remote speaker programs • Successfully sold advantages of Lantus over Levemir finishing in the top 8% in 2012 • Ranked #1 out of 78 in the region in 2012 • Finished in top 33% in 2014 (based on customer retention, conversions and new acquisitions) Informed and educated medical providers on clinical benefits of Plavix and Avapro in highly competitive cardiovascular market. • National Sales Champion in 2008 (Presidents Club) • National Sales Champion in 2010 (Presidents Club) • Recognized for highest Avapro co-pay card redemption rate of 5.92% • Surpassed the region in Lantus Solostar conversions in 2010 Contributed to successful product launch of antibiotic Ketek, first in its class of “ketolides” indicated for Bronchitis, Sinusitis and Community Acquired Pneumonia. 4 years experience in the Respiratory market promoting Azmacort, Nasacort AQ, and Allegra in highly competitive Allergy/Asthma market. Target specialists included Hospitalists, Infectious Disease Specialists, Allergists, ENTs, Pulmonologists and Dermatologists • Launched Ketek first antibiotic in new class of ketolides indicated for pneumonia, bronchitis and sinusitis • Successfully sold Nasacort AQ against market leader Flonase • Impacted dermatology market promoting Allegra for the treatment of CIU and pruritus • Ranked 53/483 in the nation in highly competitive antihistamine market for Q1 and Q2 in 2002 • 2002 “Ring Award”. Show less